(Q46915316)

26 December 2017

title

Regional metal concentrations in Parkinson's disease, other chronic neurological diseases, and control brains (English)

1 reference

26 December 2017

1 reference

Uitti RJ

1

1 reference

26 December 2017

Rajput AH

2

1 reference

26 December 2017

Rozdilsky B

3

1 reference

26 December 2017

Bickis M

4

1 reference

26 December 2017

Wollin T

5

1 reference

26 December 2017

Yuen WK

6

1 reference

26 December 2017

publication date

1 August 1989

1 reference

26 December 2017

Canadian Journal of Neurological Sciences

published in

1 reference

26 December 2017

volume

16

1 reference

26 December 2017

issue

3

1 reference

26 December 2017

page(s)

310-314

1 reference

26 December 2017

Effect of a magnesium-deficient diet on the striatal content of amines in the dog.

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100029140

7 January 2021

The effect of levodopa, lergotrile, and bromocriptine on brain iron, manganese, and copper

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100029140

7 January 2021

Simultaneous Statistical Inference

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100029140

7 January 2021

Metal chelates of l-DOPA for improved replenishment of dopaminergic pools

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100029140

7 January 2021

Metabolic modification of Parkinson's disease and of chronic manganese poisoning

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100029140

7 January 2021

Biochemistry of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100029140

7 January 2021

Chronic exposure to the fungicide maneb may produce symptoms and signs of CNS manganese intoxication.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100029140

7 January 2021

Lead neuropathy in adults and children

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100029140

7 January 2021

Effective treatment of Wilson's disease with oral zinc sulphate: two case reports.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100029140

7 January 2021

Chronic parkinsonism secondary to intravenous injection of meperidine analogues

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100029140

7 January 2021

Effect of copper deficiency on the concentrations of catecholamines and related enzyme activities in the rat brain

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100029140

7 January 2021

Aetiology of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100029140

7 January 2021

Raised cerebrospinal-fluid copper concentration in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100029140

7 January 2021

Geography, drinking water chemistry, pesticides and herbicides and the etiology of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100029140

7 January 2021

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100029140

7 January 2021

NORMAL SERUM MAGNESIUM LEVELS IN PARKINSON'S DISEASE.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100029140

7 January 2021

Intraneuronal aluminum accumulation in amyotrophic lateral sclerosis and Parkinsonism-dementia of Guam

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100029140

7 January 2021

10.1017/S0317167100029140

Identifiers

DOI

0 references

1 reference

26 December 2017